The game “Tumor Quest” seeks to improve people’s understanding of cancer.

At the helm of SkinBioTherapeutics, Catherine O’Neill and her team are exploring the ways in which probiotic bacteria can be used topically.

Could blood cells provide the ideal environment to test new drugs for neuropsychiatric disorders?

Sitting Down With... David Schoneker, Global Regulatory Director, Strategic Relationships at Colorcon.

How will the industry shape up over the next five years?

Could a text message make all the difference in ensuring the integrity of drug products?

John McCafferty, CEO of IONTAS, explains how his company’s work in mammalian cells could bring biopharmaceuticals to market faster.

What are the consequences of allowing patients to purchase cell and gene therapies directly from hospitals?

Could harnessing the power of artificial intelligence put an end to the leading cause of sight loss in the developed world?

Why are spherical nucleic acids so exciting for drug development?